Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Qianshi Xu"'
Autor:
Shiwen Huo, Jinqi Xue, Shuo Wang, Huilian Shan, Guanglei Chen, Nan Niu, Yimin Wang, Fang Qiu, Yi Zhao, Fei Xing, Xinyu Zheng, Wei Tu, Ke Li, Hai Zhao, Meiyue Tang, Qianshi Xu, Chao Liu, Yafei Zhao, Xiaofan Jiang, Zheng Pang, Keliang Zhang, Dianlong Zhang, Zhe‐Sheng Chen, Caigang Liu
Publikováno v:
MedComm, Vol 5, Iss 3, Pp n/a-n/a (2024)
Abstract Triple‐positive breast cancer (TPBC) poorly responds to current standard neoadjuvant therapy (trastuzumab plus pertuzumab and chemotherapy). Our previous MUKDEN 01 study showed a promising total pathological complete response (tpCR) rate o
Externí odkaz:
https://doaj.org/article/90fd47107198425c8ce96e8bc7172b7d
Autor:
Nan Niu, Fang Qiu, Qianshi Xu, Guijin He, Xi Gu, Wenbin Guo, Dianlong Zhang, Zhigao Li, Yi Zhao, Yong Li, Ke Li, Hao Zhang, Peili Zhang, Yuanxi Huang, Gangling Zhang, Hongbin Han, Zhengang Cai, Pengfei Li, Hong Xu, Guanglei Chen, Jinqi Xue, Xiaofan Jiang, Alireza Hamidian Jahromi, Jinshi Li, Yu Zhao, Eduardo de Faria Castro Fleury, Shiwen Huo, Huajun Li, Guy Jerusalem, Domenico Tripodi, Tong Liu, Xinyu Zheng, Caigang Liu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Neoadjuvant therapy is recommended for patients with locally advanced breast cancer. Here the authors report the results of a phase 2 clinical trial of oral neoadjuvant therapy with pyrotinib (pan-HER tyrosine kinase inhibitor), letrozole (aromatase
Externí odkaz:
https://doaj.org/article/1d9c37ba0fbf4148af08531c29508fb7
Background Breast mucinous adenocarcinoma is a group of malignant tumors of epithelial origin of the breast with a good prognosis; however, whether its treatment regimen should be consistent with that of non-specific types of breast cancer remains to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f835f23c3524dfe14e653e032ea65f
https://doi.org/10.21203/rs.3.rs-2723855/v1
https://doi.org/10.21203/rs.3.rs-2723855/v1
